NEW YORK, March 30, 2016 /PRNewswire/ -- S&P Dow
Jones Indices will make the following changes to the S&P MidCap
400 and S&P SmallCap 600 indices after the close of trading on
Friday, April 1:
- WebMD Health Corp. (NASD: WBMD) will replace SunEdison Inc.
(NYSE: SUNE) in the S&P MidCap 400. SunEdison is ranked at the
bottom of the index and has a market capitalization that is no
longer representative of the mid-cap market space.
- SciClone Pharmaceuticals Inc. (NASD: SCLN) will replace
Affymetrix Inc. (NASD: AFFX) in the S&P SmallCap 600. S&P
500 constituent Thermo Fisher Scientific Inc. (NYSE: TMO) is
acquiring Affymetrix in a deal expected to be completed soon
pending final approvals.
WebMD Health Corp. provides health information services.
Headquartered in New York, NY, the
company will be added to the S&P MidCap 400 GICS (Global
Industry Classification Standard) Internet Software & Services
Sub-Industry index.
SciClone Pharmaceuticals provides therapies for oncology,
infectious diseases, and cardiovascular disorders. Headquartered in
Foster City, CA, the company will
be added to the S&P SmallCap 600 GICS Pharmaceuticals
Sub-Industry index.
Following is a summary of the changes:
S&P MIDCAP 400
INDEX – April 1, 2016
|
|
COMPANY
|
GICS ECONOMIC
SECTOR
|
GICS
SUB-INDUSTRY
|
ADDED
|
WebMD
Health
|
Information
Technology
|
Internet Software
& Services
|
DELETED
|
SunEdison
|
Information
Technology
|
Semiconductor
Equipment
|
|
S&P SMALLCAP
600 INDEX – April 1, 2016
|
|
COMPANY
|
GICS ECONOMIC
SECTOR
|
GICS
SUB-INDUSTRY
|
ADDED
|
SciClone
Pharmaceuticals
|
Health
Care
|
Pharmaceuticals
|
DELETED
|
Affymetrix
|
Health
Care
|
Life Science Tools
& Services
|
Additions to and deletions from S&P Dow Jones Indices
do not in any way reflect an opinion on the investment merits of
the companies involved.
For more information about S&P Dow Jones Indices, please
visit www.spdji.com
About S&P Dow Jones Indices
S&P Dow Jones
Indices LLC, a part of McGraw Hill Financial, is the world's
largest, global resource for index-based concepts, data and
research. Home to iconic financial market indicators, such as the
S&P 500® and the Dow Jones Industrial
Average®, S&P Dow Jones Indices LLC has over 115
years of experience constructing innovative and transparent
solutions that fulfill the needs of investors. More assets are
invested in products based upon our indices than any other provider
in the world. With over 1,000,000 indices covering a wide range of
asset classes across the globe, S&P Dow Jones Indices LLC
defines the way investors measure and trade the markets. To learn
more about our company, please visit www.spdji.com.
S&P® is a registered trademark of Standard & Poor's
Financial Services LLC ("S&P"), a part of McGraw Hill
Financial. Dow Jones® is a registered trademark of Dow Jones
Trademark Holdings LLC ("Dow Jones"). These trademarks have been
licensed to S&P Dow Jones Indices LLC. It is not possible to
invest directly in an index. S&P Dow Jones Indices LLC, Dow
Jones, S&P and their respective affiliates (collectively
"S&P Dow Jones Indices") do not sponsor, endorse, sell, or
promote any investment fund or other investment vehicle that is
offered by third parties and that seeks to provide an investment
return based on the performance of any index. This document does
not constitute an offer of services in jurisdictions where S&P
Dow Jones Indices does not have the necessary licenses. S&P Dow
Jones Indices receives compensation in connection with licensing
its indices to third parties.
S&P DJI MEDIA CONTACTS:
David Blitzer
Managing Director and Chairman of Index Committee
New York, USA
(+1) 212 438 3907
david.blitzer@spdji.com
Soogyung Jordan
Head of Communications
New York, USA
(+1) 212 438 2297
soogyung.jordan@spdji.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/webmd-health-set-to-join-the-sp-midcap-400-sciclone-pharmaceuticals-to-join-sp-smallcap-600-300243784.html
SOURCE S&P Dow Jones Indices